[HTML][HTML] Antithrombotic therapies in COVID-19 disease: a systematic review

E Maldonado, D Tao, K Mackey - Journal of general internal medicine, 2020 - Springer
Background Infection with coronavirus SARS-CoV-2, causing COVID-19 disease, leads to
inflammation and a prothrombotic state. Objective This rapid systematic review aims to …

[HTML][HTML] Incidence of venous thromboembolism and mortality in patients with initial presentation of COVID-19

D Giannis, MA Barish, M Goldin, SL Cohen… - Journal of thrombosis …, 2021 - Springer
Venous thromboembolism (VTE) has emerged as an important issue in patients with COVID-
19. The purpose of this study is to identify the incidence of VTE and mortality in COVID-19 …

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry

D Giannis, SL Allen, J Tsang, S Flint… - Blood, The Journal …, 2021 - ashpublications.org
Thromboembolic events, including venous thromboembolism (VTE) and arterial
thromboembolism (ATE), and mortality from subclinical thrombotic events occur frequently in …

Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19

GN Nadkarni, A Lala, E Bagiella, HL Chang… - Journal of the American …, 2020 - jacc.org
Background Thromboembolic disease is common in coronavirus disease-2019 (COVID-19).
There is limited evidence on the association of in-hospital anticoagulation (AC) with …

[HTML][HTML] Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis

K Boonyawat, P Chantrathammachart, P Numthavaj… - Thrombosis journal, 2020 - Springer
Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic,
the incidence of thromboembolism has been increasingly reported. The aim of this …

[HTML][HTML] Thromboembolic risk in hospitalized and nonhospitalized COVID-19 patients: a self-controlled case series analysis of a nationwide cohort

FK Ho, KKC Man, M Toshner, C Church… - Mayo Clinic …, 2021 - Elsevier
Objective To assess the associations between coronavirus disease 2019 (COVID-19)
infection and thromboembolism including myocardial infarction (MI), ischemic stroke, deep …

Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis

FA Klok, M Kruip, NJM Van der Meer, MS Arbous… - Thrombosis research, 2020 - Elsevier
Introduction We recently reported a high cumulative incidence of thrombotic complications in
critically ill patients with COVID-19 admitted to the intensive care units (ICUs) of three Dutch …

[HTML][HTML] Incidence of thrombotic complications in COVID-19: on behalf of ICODE: The International COVID-19 Thrombosis Biomarkers Colloquium

WJ Jenner, DA Gorog - Journal of thrombosis and thrombolysis, 2021 - Springer
A high incidence of thrombosis in hospitalised patients with COVID-19 was identified early
during the pandemic. Accurately quantifying thrombotic risk may assist prognosis and guide …

Predictors and mortality risk of venous thromboembolism in patients with COVID-19: systematic review and meta-analysis of observational studies

G Agarwal, A Hajra, S Chakraborty… - Therapeutic …, 2022 - journals.sagepub.com
Introduction: Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection resulting in COVID-19 disease is associated with widespread inflammation and a …

[HTML][HTML] A comprehensive review of vascular complications in COVID-19

Y Acharya, A Alameer, G Calpin, M Alkhattab… - Journal of Thrombosis …, 2022 - Springer
This study aims to review the available literature pertinent to vascular complications in
COVID-19. A systematic search was performed using PubMed and Google Scholar to …